Benitec Biopharma
BNTC | NASDAQ
$8.54
-$0.50 (-5.53%)
At close: Nov 16, 2026, 4:00 PM ET
$8.54
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:10 PM ET
-5.53%
(1D)No price chart data available for 1D timeframe.
Rating
22.8
-1.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #970/1021 (Top 95%)
Key Statistics
Market Data
Market Cap $422.62M
1D Range
8.49 9.30
52W Range
8.11 14.08
Valuation (TTM)
PE -8.29
PB 2.49
EV/EBITDA -4.58
Valuation (NTM)
Forward PE N/A
Forward PEG -0.36
Price Target $15.50
Cash Flow
FCF Yield -4.1%
SBC Adj. FCF Yield -8.6%
SBC Impact -110.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-74.7%
Dil EPS 3Y | 5Y 26.9% |
47.4%
FCF 3Y | 5Y 5.7% |
-7.9%
Returns
ROA -27.6%
ROE -27.6%
ROIC -32.8%
Financial Health
Net Cash
$175.73M
Current Ratio 19.62
Interest Coverage 40.19
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA int...
Sector Healthcare
Industry Biotechnology
Employees 24
IPO Date Jun 24, 2014
Website benitec.com
Fiscal Year July - June
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$17.00
Upside
+99.06%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BNTC